Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc. (BOLT) — Form 8-K: Current report
About this filing
Bolt Biotherapeutics, Inc. (BOLT) filed an 8-K on Oct 6, 2026 reporting entry into a material agreement (Item 1.01).
Key facts
- Item 1.01 · Entry into a material agreement
More BOLT filings
- 4
Filed Nov 10, 2026
- 3
Filed Nov 6, 2026
- SC 13G
Filed Nov 6, 2026
- 4
Filed Oct 27, 2026
- 3
Filed Oct 27, 2026
- 8-K
Filed Oct 23, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.